Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Clinical trial NCT03654716 · COMPLETED
Trial details
- NCT number
- NCT03654716
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2023-07-17
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.